Study to compare a tacrolimus Hexal® based regimen versus a Prograf® based regimen in renal transplantation

Update Il y a 4 ans
Reference: EUCTR2011-003795-36

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

PHASE I: To demonstrate that the pharmacokinetics of Tacrolimus Hexal® assessed by the ratio of the AUC0-12h over a one month period post-transplantation is comparable to Prograf® in renal transplant patients. PHASE II (including the patients enrolled in Phase I, Phase II study will not be conducted): To demonstrate non-inferiority in renal function assessed by glomerular filtration rate (Nankivell formula) between both treatment arms at month 6 post-transplantation in renal transplant patients.


Inclusion criteria

  • renal transplantation

Links